Stay updated on EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.

Latest updates to the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page
- Check6 days agoChange DetectedNew revision added to the record history: v3.5.0 appears, indicating updates since the previous revision (v3.4.3).SummaryDifference0.1%

- Check13 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 in the Record History.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedA new revision (v3.4.2) was added to the Record History and the previous revision (v3.4.1) removed, reflecting a minor administrative update; this does not affect study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedA new revision entry v3.4.1 was added to the Record History and the v3.4.0 entry was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedThe updates introduce UI/display changes such as a glossary toggle, color-coded highlights for changes, and a new revision label (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check71 days agoChange DetectedA new revision entry v3.3.4 was added to the record history and the previous v3.3.3 entry was removed.SummaryDifference0.1%

Stay in the know with updates to EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.